Description
This role will serve as the US Real-World Evidence and Health Outcomes Research (RWE&HOR) lead dedicated to supporting GSK's oncology hematology portfolio.
The successful candidate will have a proven record of health economics and outcomes research strategy development and execution, leadership and research goal attainment.
Responsibilities:
- Lead high-priority RWE/HO studies supporting hematology and potential new indication launches in the US.
- Lead Value Evidence and Strategy Team (VEST) meetings, aligning cross-functional stakeholders on evidence priorities, strategy, and execution.
- Conduct RWE&HOR research by aligning across cross-functional stakeholders.
- Ensure strategic alignment with key internal stakeholders (US medical, commercial, market access, and Global RWE/HOR, Global medical affairs and market access).
- Manage vendors in the execution of HEOR projects.
- Maintain a budget spreadsheet along with study timelines.
- Ensure that RWE&HOR research studies are executed and tracked appropriately.
- Develop and maintain strong alignment with the Field Based Payer Medical Teams to obtain insights from external customers.
Requirements:
- MS or PhD in health economics and outcomes research or related discipline (economics, sociology, epidemiology, other).
- 3+ years' experience within the pharmaceutical industry, including field research-facing role, or related field within US Oncology experience.
- Strong cross-functional leadership and stakeholder management skills, with the ability to negotiate and clearly communicate the value and need for real-world evidence to key external Oncology customers.
- Experience developing and executing RWE&HOR research and real-world data plans by aligning both with internal and external stakeholders.
Benefits:
- Comprehensive benefits program, including digital fluency, enterprise thinking, external stakeholder management, high impact communication, and patient impact.
For more fresh new jobs, check out yubhub.co.